Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 29:2020:9520309.
doi: 10.1155/2020/9520309. eCollection 2020.

Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis

Affiliations

Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis

Beata Bieniaś et al. Dis Markers. .

Abstract

Renal tubulointerstitial fibrosis caused by congenital ureteropelvic junction obstruction (UPJO) may lead to the development of obstructive nephropathy (ON) and the impairment of kidney function. Hence, the identification of early biomarkers of this condition might be of assistance in therapeutic decisions. This study evaluates serum and urinary metalloproteinases MMP-1, MMP-2, and MMP-9 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 as potential biomarkers of ON in children with congenital unilateral hydronephrosis (HN) caused by UPJO. Forty-five (45) children with congenital HN of different grades of severity and twenty-one (21) healthy controls were enrolled in the study. Urinary and serum concentrations of MMP-1, MMP-2, MMP-9, TIMP-1 and TIMP-2 were measured using specific ELISA kits. The urinary excretions were expressed as biomarker/creatinine (Cr) ratios. To evaluate the extracellular matrix remodelling process activity, the serum and urinary MMP-1, -2, -9/TIMP-1, -2 ratios were also calculated. In comparison with the controls, patients with HN, independent of the grade, showed significantly increased median serum MMP-9, TIMP-1, and TIMP-2, median urinary MMP-9/Cr, and TIMP-2/Cr ratios. Lower median values of serum MMP-2/TIMP-1, MMP-9/TIMP-1 in patients with HN were also revealed. Additionally, higher urinary MMP-2/Cr, lower urinary MMP-2/TIMP-2, and lower serum MMP-9/TIMP-2 ratios were observed in patients with HN grades 3 and 4. Patients with ON diagnosed by renal scintigraphy had a significantly higher median serum MMP-9 concentration and lower median serum MMP-9/TIMP-1, -2 ratios in comparison with those without this condition. Patients with nonglomerular proteinuria had a significantly higher median serum TIMP-1 concentration, a higher median urinary TIMP-2/Cr ratio, and a lower serum MMP-9/TIMP-1 ratio compared to those without this symptom. The relationship between the measured biomarkers and the relative function of the obstructed kidney showed no correlations. The ROC curve analysis showed a promising diagnostic profile for the detection of ON for serum MMP-9 and the serum MMP-9/TIMP-1 and MMP-9/TIMP-2 ratios. In conclusion, the results of this study suggest that patients with HN, particularly with grades 3 and 4, are at higher risk of renal tubulointerstitial fibrosis. The noninvasive markers of this condition considered are urinary MMP-2/Cr and MMP-9/Cr, serum MMP-9, serum and urinary MMP-2, MMP-9/TIMP-1, -2. Additionally, serum MMP-9 and MMP-9/TIMP-1, -2 may become promising markers of ON.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Serum concentration of (a) MMP-9 and serum ratios of (b) MMP-9/TIMP-1 and (c) MMP-9/TIMP-2 in patients with obstructive nephropathy (ON) and hydronephrosis without obstructive nephropathy (HN without ON).
Figure 2
Figure 2
Serum concentrations of (a) TIMP-1 and (b) TIMP-2 and (c) serum MMP-9/TIMP-1 ratio in hydronephrotic patients with and without proteinuria.
Figure 3
Figure 3
ROC analysis for the (a) serum MMP-9, (b) serum MMP-9/TIMP-1, and (a) serum MMP-9/TIMP-2 ratios in the detection of obstructive nephropathy (patients with obstructive nephropathy (ON) vs. patients with hydronephrosis without obstructive nephropathy (HN without ON)).

Similar articles

Cited by

References

    1. Chevalier R. L., Forbes M. S., Thornhill B. A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International. 2009;75(11):1145–1152. doi: 10.1038/ki.2009.86. - DOI - PubMed
    1. Chevalier R. L., Thornhill B. A., Forbes M. S., Kiley S. C. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatric Nephrology. 2010;25(4):687–697. doi: 10.1007/s00467-009-1316-5. - DOI - PubMed
    1. Toi M., Ishigaki S., Tominaga T. Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Research and Treatment. 1998;52(1-3):113–124. doi: 10.1023/A:1006167202856. - DOI - PubMed
    1. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circulation Research. 2003;92(8):827–839. doi: 10.1161/01.RES.0000070112.80711.3D. - DOI - PubMed
    1. Catania J. M., Chen G., Parrish A. R. Role of matrix metalloproteinases in renal pathophysiologies. American Journal of Physiology-Renal Physiology. 2007;292(3):F905–F911. doi: 10.1152/ajprenal.00421.2006. - DOI - PubMed

MeSH terms